RACCOLTA DEI DIRITTI DI COPIA PRIVATA NEL SETTORE AUDIOVISIVO. L’AGCM AVVIA UN’ISTRUTTORIA NEI CONFRONTI DELLE C.D. “COLLECTING SOCIETIES”

marketude Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property, Intellectual Property

[x_icon type="tag"] Intellectual Property, Society, Perspectives

PRIMO RINVIO EX ARTICOLO 22 DEL REGOLAMENTO EUROPEO SULLE CONCENTRAZIONI. LA COMMISSIONE APRE UN’INDAGINE SULL’ACQUISIZIONE GRAIL/ILLUMINA

marketude Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA CLASSIFICAZIONE NAZIONALE DEI MEDICINALI PER USO UMANO AUTORIZZATI IN UN DIVERSO STATO MEMBRO COME NON SOGGETTI A PRESCRIZIONE MEDICA

marketude Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

SOCIAL E MINORI, LA SFIDA DEI LEGALI È COME TUTELARE LA LIBERTÀ DI RETE

marketude Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity

[br]

DISPOSITIVI MEDICI. ENTRA IN VIGORE IL REGOLAMENTO 2017/745

marketude Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

DIRITTI UMANI. ANCHE L’UNIONE EUROPEA ADOTTA UN REGIME GLOBALE DI SANZIONI

marketude EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, Globally Minded

[x_icon type="tag"] EU and Competition, Perspectives, Society, Globally Minded

MISSBRAUCH DER MARKTBEHERRSCHENDEN STELLUNG. DIE ITALIENISCHE WETTBEWERBSBEHÖRDE VERHÄNGT DEM INTERNET-RIESEN GOOGLE EINE GELDBUSSE VON ÜBER 100 MILLIONEN EURO

marketude Connectivity, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, Esmeralda Dedej, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT, IT & TMT

[x_icon type="tag"] EU and Competition, Connectivity, IT&TMT

UN ALTRO EPISODIO DELLA SAGA AVASTIN/LUCENTIS. IL NUOVO RINVIO DEL CONSIGLIO DI STATO ALLA CORTE DI GIUSTIZIA

marketude Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences

[x_icon type="tag"] Litigation, Pharmaceuticals and Life Sciences, Society

SICUREZZA E AFFIDABILITÀ I PILASTRI DEL NUOVO REGOLAMENTO EUROPEO SULL’INTELLIGENZA ARTIFICIALE

marketude Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

[x_icon type="tag"] EU and Competition, Data Protection and Cybersecurity, Perspectives

CRYPTOARTE: TRA DIRITTO, TECNOLOGIE E NUOVE FORME DI INVESTIMENTO – Webinar Bocconi Alumni Community, April 21st, 2021

marketude Gaspare Roma, Gaspare Roma, Gaspare Roma, Gaspare Roma, Gaspare Roma, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci, Giulietta Minucci

[x_icon type="map-marker"] Webinar Bocconi Alumni Community[br]
[x_icon type="calendar"] April 21st, 2021[br]
[x_icon type="user"] Silvia Doria, Gaspare Roma, Giulietta Minucci

DE BERTI JACCHIA VINCE PER GLAXOSMITHKLINE SULLA RESPONSABILITÀ DA PRODOTTI FARMACEUTICI

marketude David Maria Santoro

Sono state pubblicate in rapida successione tre decisioni che hanno definito altrettanti procedimenti giudiziari nei quali De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. ed altre società collegate dell’omonimo gruppo farmaceutico anglosassone, ritenute responsabili di danni – patrimoniali e non – legati all’impiego di propri prodotti.

DAC 7, LOTTA ALL’EVASIONE CON L’AIUTO DELLE BIG TECH: ECCO GLI OBIETTIVI DELLA DIRETTIVA

marketude Alessandro Foti, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press, In the Press

[x_icon type="tag"] Tax

FROM LAW NO. 21/2021 RATIFYING LAW DECREE NO. 183/2020 WITH AMENDMENTDS TO LAW DECREE NO. 41/2021 (“SOSTEGNI DECREE”): MEASURES IN MATTER OF EMPLOYMENT

marketude Coronavirus, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Employment and Pensions, Isabella Basilico, Isabella Basilico

[x_icon type="tag"] Coronavirus, Employment and pensions